Webinar: Oncology trials in a shifting economical and geopolitical landscape

Currently, clinical trials are experiencing a rise in complexity, encompassing multiple regions and demanding substantial resources. This trend significantly impacts sponsors, who face the timelines and cost control constraints. As a result, the establishment of an...

In recent years, biotech companies face pressure to optimize clinical trial operations while managing costs, ensuring regulatory compliance, and maintaining flexibility. This is where Functional Service Provision (FSP) comes in. FSP offeres a scalable, flexible...

For biotech and pharmaceutical companies, the challenge isn’t just innovation but execution too. Functional Service Provision (FSP) enables organizations to optimize clinical trials without the bottlenecks of traditional outsourcing. As competition intensifies and...

The U.S. Food and Drug Administration’s (FDA) draft guidance on Diversity Action Plans (DAPs) is a significant step towards addressing the underrepresentation of diverse populations in clinical research. Released in June 2024, this guidance aligns with broader efforts...